Dirk Jan Hijnen

Atopic Dermatitis is the most common chronic inflammatory skin disease and has a profound effect on the quality of life of patients. A major issue that we are facing is the heterogeneity of the disease. My research focuses on the mechanism that differentiate patients with different clinical phenotypes to better understand the disease, find new targets for treatment, and to predict treatment response.